Life Science LeaderANAVEX® Life Sciences Corp.Jul 31, 20151 min readAlzheimer’s Drug Development: Not An Easy Path To Pursue
Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease
Anavex Life Sciences to Present Oral Blarcamesine Data at the 18th Clinical Trials on Alzheimer’s Disease (CTAD) Conference
